Abstract
Some amyloid-derived peptides show their toxic effects only after a long “aging” period performed several days at pH 7.4 and 37 C for cluster formation. Our experiments show that long aging of beta-amyloid[25-35] under physiological conditions results in peptide bond cleavage between Asn27 and Lys28. Relatively short incubation time (24 hours) and absence of Ca2+ ions prevent peptide cleavage and results in good aggregation of beta-amyloids.
Keywords: AMYLOID PEPTIDE, Alzheimer disease
Protein & Peptide Letters
Title: In Vitro Degradation Of beta-Amyloid[25-35] Peptide
Volume: 8 Issue: 6
Author(s): Krisztina Jost, Jozsef Varga, Botond Pence and Marta Zarandi
Affiliation:
Keywords: AMYLOID PEPTIDE, Alzheimer disease
Abstract: Some amyloid-derived peptides show their toxic effects only after a long “aging” period performed several days at pH 7.4 and 37 C for cluster formation. Our experiments show that long aging of beta-amyloid[25-35] under physiological conditions results in peptide bond cleavage between Asn27 and Lys28. Relatively short incubation time (24 hours) and absence of Ca2+ ions prevent peptide cleavage and results in good aggregation of beta-amyloids.
Export Options
About this article
Cite this article as:
Jost Krisztina, Varga Jozsef, Pence Botond and Zarandi Marta, In Vitro Degradation Of beta-Amyloid[25-35] Peptide, Protein & Peptide Letters 2001; 8 (6) . https://dx.doi.org/10.2174/0929866013409076
DOI https://dx.doi.org/10.2174/0929866013409076 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alzheimers Disease (AD) and Mild Cognitive Impairment (MCI) Patients are Characterized by Increased BDNF Serum Levels
Current Alzheimer Research Different Levels of Activity in the Left Intraparietal Sulcus Triggered by Lasting and Unlasting Cues in the Posner Task
Neuroscience and Biomedical Engineering (Discontinued) From Nucleic Acids to Drug Discovery: Nucleobases as Emerging Templates for Drug Candidates
Current Medicinal Chemistry NTproBNP: An Important Biomarker in Cardiac Diseases
Current Topics in Medicinal Chemistry Nur77 Family of Nuclear Hormone Receptors
Current Drug Targets - Inflammation & Allergy Oxidation of Endobiotics Mediated by Xenobiotic-Metabolizing Forms of Human Cytochrome P450
Current Drug Metabolism Serotonin Selective Reuptake Inhibitors (SSRIs) and Female Sexual Dysfunction (FSD): Hypothesis on its Association and Options of Treatment
Current Drug Targets The Function and Integrity of the Neurovascular Unit Rests Upon the Integration of the Vascular and Inflammatory Cell Systems
Current Neurovascular Research Solution NMR Study of the Transmembrane Domain of Single-Span Membrane Proteins: Opportunities and Strategies
Current Protein & Peptide Science Development of New Drugs for COPD
Current Medicinal Chemistry Cigarette Smoke-Induced Proteostasis Imbalance in Obstructive Lung Diseases
Current Molecular Medicine Illicium verum Extract Exhibited Anti-inflammatory Action in Rodents
Letters in Drug Design & Discovery Visuospatial Memory in Healthy Elderly, AD and MCI: A Review
Current Aging Science Advances in Stem Cells Transplantation for the Therapy of Parkinson’s Disease
Current Stem Cell Research & Therapy Meet Our Editorial Board Member
Current Neuropharmacology Tetraspanins - Gateways for Infection
Infectious Disorders - Drug Targets Managing Comorbidity in COPD: A Difficult Task
Current Drug Targets Vitamins and Type 2 Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets Genome-Wide Association Studies: Is there a Genotype for Cognitive Decline in Older Persons with Type 2 Diabetes?
Current Pharmaceutical Design Obesity and Arterial Compliance Alterations
Current Vascular Pharmacology